In last trading session, P3 Health Partners Inc (NASDAQ:PIII) saw 1.53 million shares changing hands with its beta currently measuring 0.94. Company’s recent per share price level of $0.18 trading at $0.0 or -0.05% at ring of the bell on the day assigns it a market valuation of $65.86M. That closing price of PIII’s stock is at a discount of -394.44% from its 52-week high price of $0.89 and is indicating a premium of 16.67% from its 52-week low price of $0.15. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.59 million shares which gives us an average trading volume of 2.46 million if we extend that period to 3-months.
For P3 Health Partners Inc (PIII), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.80. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
P3 Health Partners Inc (NASDAQ:PIII) trade information
Upright in the red during last session for losing -0.05%, in the last five days PIII remained trading in the green while hitting it’s week-highest on Thursday, 03/27/25 when the stock touched $0.18 price level, adding 9.09% to its value on the day. P3 Health Partners Inc’s shares saw a change of -18.45% in year-to-date performance and have moved 2.98% in past 5-day. P3 Health Partners Inc (NASDAQ:PIII) showed a performance of 0.16% in past 30-days. Number of shares sold short was 2.34 million shares which calculate 3.26 days to cover the short interests.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -8.00% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 51.06% while estimates for its earnings growth in next 5 years are of 41.31%.
P3 Health Partners Inc (NASDAQ:PIII)’s Major holders
Insiders are in possession of 62.08% of company’s total shares while institution are holding 13.27 percent of that, with stock having share float percentage of 35.00%. Investors also watch the number of corporate investors in a company very closely, which is 13.27% institutions for P3 Health Partners Inc that are currently holding shares of the company. ALYESKA INVESTMENT GROUP, L.P. is the top institutional holder at PIII for having 15.95 million shares of worth $7.18 million. And as of 2024-06-30, it was holding 11.6756 of the company’s outstanding shares.
The second largest institutional holder is ARMISTICE CAPITAL, LLC, which was holding about 7.9 million shares on 2024-06-30. The number of shares represents firm’s hold over 5.7833 of outstanding shares, having a total worth of $3.56 million.
